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ABSTRACT: Twelve climbers with not been exposed in the last 12 months at high altitude were 
evaluated using verbal, spatial, reasoning and numerical tasks from Thurstone’s (1969) Primary 
Mental Abilities (PMA) test. These tasks were undertaken before and immediately after 
completing the Richalet et al. (1988) Normobaric Hypoxic (NH) test, which evaluates the acute 
mountain sickness (AMS) risk using a FiO2 of 11.5% during rest and exercise. A control group of 
eight climbers did not perform the NH test, so as to rule out the possible learning effect of the 
PMA test. Four participants (33%) from the experimental group were classified as having high-
susceptibility to AMS. However, the PMA test performed after the NH test did not significantly 
differ from the one carried out before the NH test or from the cognitive abilities measured in 
the control group (p > .05). 
KEYWORDS: Acute mountain sickness, normobaric hypoxia, basic cognitive function. 
SUSCEPTIBILIDAD DEL MAL AGUDO DE MONTAÑA Y FUNCIONES COGNITIVAS BÁSICAS 
TRAS UNA BREVE EXPOSICIÓN A UNA ALTITUD SIMULADA DE 4.800 M 
RESUMEN: Se evaluaron doce escaladores, que no habían estado expuestos en los últimos 12 
meses a gran altitud, utilizando el test de Aptitudes Mentales Primarias (PMA) de Thurstone 
(1969). Se realizó el test antes e inmediatamente después de completar el test de Hipoxia 
Normobárica (HN) de Richalet et al. (1988) que evalúa el riesgo del mal agudo de montaña (MAM) 
usando una FiO2 de 11.5% durante el ejercicio y en reposo. Un grupo control de ocho 
escaladores, no realizó la prueba de HN, con el fin de descartar el posible efecto de aprendizaje 
del test PMA. Cuatro participantes (33%) del grupo experimental fueron clasificados como de 
alta susceptibilidad al MAM. Sin embargo, los resultados del PMA realizado después del test de 
HN no fue significativamente diferente del llevado a cabo antes de la prueba HN en ninguna de 
las habilidades cognitivas medidas en el grupo control (p > .05). 
PALABRAS CLAVE: Mal agudo de montaña, hipoxia normobárica, funciones cognitivas básicas. 
SUSCETIBILIDADE DO MAL AGUDO DE MONTANHA E FUNÇÕES COGNITIVAS BÁSICAS APÓS 
UMA BREVE EXPOSIÇÃO A UMA ALTITUDE SIMULADA DE 4.800 M 
RESUMO: Foram avaliados doze escaladores, que não tinham estado expostos nos últimos 12 
meses a grande altitude, utilizando o teste de Aptidões Mentais Primárias (PMA) de Thurstone 
(1969). O teste foi realizado antes e imediatamente depois de completar o teste de Hipoxia 
Normobárica (HN) de Richalet et al. (1988) que avalia o risco do mal agudo de montanha (MAM) 
usando uma FiO2 de 11.5% durante o exercício e em repouso. Um grupo de controlo de oito 
escaladores não realizou a prova de HN a fim de excluir o possível efeito de aprendizagem do 
teste de PMA. Quatro participantes (33%) do grupo experimental foram classificados como de 
alta suscetibilidade ao MAM. Contudo, os resultados do PMA realizado depois do teste de HN 
não foram significativamente diferentes dos obtidos antes da prova de HN em nenhuma das 
habilidades cognitivas medidas no grupo de controlo (p > .05). 
PALAVRAS CHAVE: mal agudo de montanha, hipoxia normobárica, funções cognitivas básicas. 
 
The impact of environmental hypoxia on the central nervous 
system has been a topic of scientific interest for many decades. 
A varied picture of neuropsychological disturbances (memory, 
learning, attention, processing speed, decision-making, sensorial 
perception, motor control or cognitive flexibility) has emerged 
from analyses during or after exposure to a wide range of real or 
simulated high and extreme altitudes (Virués-Ortega, Buela-
Casal, Garrido, & Alcázar, 2004). Cerebral function may be 
affected in relation to altitude level and ascent rate (Wilson, 
Newmans, & Imray, 2009). Cognitive processes show particular 
sensitivity to brain oxygen availability, although at altitudes 
below 3000 m there seems to be little effect on human 
performance (Banderet & Burse, 1991). 
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In agreement to Marsillas, Rial, Isorna & Alonso (2014), 
although we take in account that different studies have made 
efforts to identify the psychological variables that can be on the 
basis of sports performance, there is no agreement yet about 
which may truly be the most relevant. Nevertheless, “On the 
mountain there is no only the need to be prepared technically 
and physically but also psychologically. The combination of these 
three variables provides a good mountaineer preparation” 
(Allueva, Nerín, Ayora, Morandeira, & San Vicente, 2010, p. 133). 
Nowadays, a large number of people ascend to high altitudes 
for recreational or professional purposes, and the risk of 
suffering from the various forms of altitude illness, and 
especially acute mountain sickness (AMS), is well known (Hackett 
& Roach, 2001). In recent years, an increasing number of 
mountaineering enthusiasts have also begun to practice sports 
requiring rapid ascents, very brief stays and fast withdrawal from 
high altitude (above 4000 m, in a substantial amount of cases); 
although the time period is usually insufficient to develop AMS, 
the neuropsychological risk derived from acute hypoxia does 
exist. Such is the case when practicing heli-skiing, skydiving, and 
other activities involving flying for short periods using different 
types of non-engine propelled aerial devices such as hang-
gliders and paragliders. Such activities require accurate cognitive 
performance in the aforementioned environmental conditions, 
both at peak altitude and during descent. Even when light 
exercise is performed just before hypoxia reverts, hypoxemia 
normalization seems to be considerably delayed (Smith, 2007). 
Although it is believed that people who suffer from AMS are 
especially susceptible to cognitive change (Mackintosh, Thomas, 
Olive, Chesner, & Knight, 1988; Regard et al., 1991; White, 1984), 
there is evidence of dissociation between the time course of both 
disorders. The functioning of some neurocognitive domains 
begins to decline relatively quickly under moderate-to-severe 
acute hypoxia (Fowler & Nathoo, 1997; Koller, Bischoff, Bührer, 
Felder, & Schopen, 1991; Truszczyński, Mieczyslaw, Biernacki, & 
Kowalczuk, 2009; Tsarouchas, Benedek, Bezerianos, Benedek, & 
Keri, 2008; Van der Post et al., 2002), although performance 
impairment may be delayed and tends to improve after several 
hours of sustained exposure when AMS symptoms usually start 
to appear (Banderet & Shukitt-Hale, 2002; Shukitt-Hale, 
Banderet, & Lieberman, 1991). Nevertheless, the minimum 
threshold, duration and speed of onset of transient hypoxic 
stress, resulting from different situations, required to impair 
human brain function, and especially the recovery from such 
stress, are controversial issues (Bahrke & Shukitt-Hale, 1993; 
Fowler, Paul, Porlier, Elcombe, & Taylor, 1985; Hopkins & Jackson, 
2006; Hornbein, Townes, Schoene, Sutton, & Houston, 1989; Lim, 
Alexander, LaFleche, Schnyer, & Verfaellie, 2004; Truszczyński et 
al., 2009). What is more, the possible link between residual 
cognitive impairment induced by brief normobaric hypoxic 
exposure and AMS risk has not been established.  
With the main purpose of establishing whether single and brief 
exposure to simulated high-altitude could be useful to relate 
AMS and cognitive risks, we aimed to evaluate the basic cognitive 
abilities before and just after performing a hypoxic test specific 
for AMS susceptibility, by measuring the physiological response 
to a sudden oxygen reduction.  
 
METHOD 
Participants 
The experimental group (EG) was made up of 12 male non-
acclimatized climbers aged 36.8 (SD = 6.2) years on average, with 
a mean height of 175.1 (SD = 6.7) cm, and average body weight 
of 75.7 (SD = 8.5) kg. All of them were members of the Spanish 
Armed Forces’ High Mountain Military Group (GMAM). One 
subject (no. 10) had climbed to an altitude of almost 5000 m. Five 
participants (nos. 1, 4, 7, 8 and 9) had achieved altitudes of over 
6000 m, three participants (nos. 2, 5 and 6) had ascended to over 
7000 m, and the remaining three (nos. 3, 11 and 12) had climbed 
to over 8000 m. The altitudes attained ranged from 4850 m to 
8201 m. Altogether, the climbers had participated in a total of 19 
expeditions to mountains over 7000 m, with 593 hours and 64 
hours of accumulated exposure above 7000 m and 8000 m, 
respectively, and had never used supplementary oxygen when 
climbing. All of them lived at altitudes below 1000 m, and during 
the previous 4 months they had not ascended to over 2500 m. 
Some of the climbers (nos. 3, 4, 5, 7, 9 and 11) had occasionally 
experienced slight headaches at high-altitude, but none had 
suffered from the severe forms of altitude sickness attributed to 
hypoxia, although they had never previously been administered 
a specific questionnaire for AMS. None of them had ever taken 
analgesics or acetazolamide for AMS prophylaxis. All the 
participants were non-smokers who did not habitually consume 
pharmacological substances or have a medical history of 
neuropsychological disturbances. One climber (subject no. 13), 
who suffered a syncope induced by the hypoxic test, was duly 
excluded from the study. 
 
Materials and Procedure 
The study protocol was approved in advance by the local 
University Institutional Ethical Review Committee, and each 
subject provided written informed consent before participating.   
 
Hypoxic test 
The exercise laboratory was located 200 m above sea level, with 
a barometric pressure ranging between 1002-1009 hPa, a 
temperature between 19ºC and 22ºC, and relative humidity 
between 40% and 60%. One week before the Normobaric 
Hypoxic (NH) test, participants were evaluated by means of a 
cardiovascular physical examination, resting electrocardiogram 
and maximal exercise test, with the main objective of ruling out 
myocardial ischemia and arrhythmias. The entire NH test took 
place in the morning, 3 hours after a light breakfast that did not 
include beverages with potential depressant or stimulant effects. 
The NH test was designed by Richalet et al. (1988) to identify 
populations with particular susceptibility to AMS, and involves 4 
successive phases each lasting 4 to 5 minutes. Acute forms of 
normoxia (N) and hypoxia (H) conditions are alternated during 
rest and exercise. The participants’ cardiac function was 
continuously monitored throughout the NH test by means of a 
12-lead telemetric electrocardiogram (X-Scribe II, Mortara Inst., 
Milwaukee, WI, USA). Pulmonary gas exchange was measured 
using a breath-by-breath automated gas analysis system (Vmax 
Spectra 29 C, SensorMedics Co., Yorba Linda, CA, USA), which 
was calibrated before each test in relation to volume, flow and 
O2 and CO2 reference mixtures balanced in nitrogen. Pulmonary 
samples were obtained by means of a facial mask (Hans 
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Rudolph, Kansas, CO, USA) joined to a bi-directional 
pneumotachograph connected to a two-way valve. Hypoxic gas 
was obtained by a mixture production system (Altitrainer 200, 
SMTEC, Geneva, Switzerland) using nitrogen from a tank. It was 
calibrated before each test to obtain a simulated altitude of 4800 
m. The gas mixture was readjusted during the first seconds of 
the hypoxic phase until a stable fractional concentration of 
11.5% of oxygen was obtained in inspired gas (FiO2) for 10 
minutes (5 minutes resting, and 5 minutes during exercise). The 
FiO2 was reduced in the acute form, as the FiO2 is 20.9% in 
normoxia. Arterial oxygen saturation was continuously 
measured by indirect oximetry (Oximax Nelcor N-595, Tyco, 
Pleasanton, CA, USA) with an infrared sensor situated in the 
earlobe. Blood pressure was manually measured every 2 
minutes in the left arm using an analogical sphygmomanometer. 
The exercise in the N (5 minutes) and H (5 minutes) phases was 
performed using an electromagnetic cycle ergometer (Ergoline 
900 OEM, Ergometrics, Bitz, Germany). Participants aimed to 
cycle at 60 r.p.m. and a different work rate (WR) was selected for 
each subject to obtain a metabolic steady state. The aim was to 
stabilize cardiac frequency between 130 and 150 beats·min-1. To 
discard the potential psychological influence of the test, 
participants were unable to see the displays and monitors, which 
were situated both behind and in front of them. In addition, 
participants were not told when they were breathing ambient air 
or the hypoxic mixture. The following 4 main physiological 
parameters were recorded for the NH test evaluation: 
pulmonary ventilation (VE, L·min-1 BTPS), respiratory rate (RR, 
min-1), heart rate (HR, min-1), and peripheral oxygen saturation 
(SpO2, %). For the final evaluation, we calculated the average of 
the instantaneous data obtained during the final 2 minutes of 
each phase when the steady state was achieved. For the 
stratification of the AMS risk, we also applied the following data 
proposed by Richalet et al. (1988) & Richalet & Herry (2006): CRE: 
HR response in relation to SpO2 during exercise under N and H 
phases (ΔHR·ΔSpO2-1; normal value > .56 beat·min-1·%-1); VRE: VE 
response in relation to SpO2 during exercise under N and H 
phases in relation to the body weight (ΔVE·ΔSpO2-1/kg; normal 
value > .36 L·min-1·%-1·kg-1); ΔSpO2E: difference in SpO2 between 
N and H phases during exercise (normal value < 26%); ΔSpO2R: 
difference of SpO2  between N and H phases during rest (normal 
value < 15%); RREH: RR during exercise under H (normal value < 
26 beat·min-1). Criteria for high-risk of AMS were defined as 
abnormal data in at least one of the first three parameters, and 
increased risk was characterized by abnormal data in one of the 
last two parameters (Richalet & Herry, 2006). 
 
Cognitive assessment 
The EG was submitted to cognitive evaluation by means of 
Thurstone’s Primary Mental Abilities (PMA) test (Thurstone, 
1969), which is a practical instrument in applied psychology to 
assess mental processing speed by means of a simple model of 
independent group factors of intelligence. Each subject was 
invited to perform the PMA test before and immediately after 
completing the NH test. Participants answered 4 of the 5 PMA 
sub-tests: 1) Factor V (verbal comprehension), which involves the 
ability to understand and express ideas through the written or 
spoken word by means of a vocabulary test. This sub-test 
consists of multiple choice questions in which the participants 
are requested to find synonyms for the proposed words. 2) The 
Factor S (spatial visualization) involves the ability to imagine and 
conceive objects in two or three dimensions. It is measured by a 
test requiring the mental rotation of images depicting different 
objects. This sub-test includes different elements, each featuring 
a geometric model and 6 similar figures. Participants must 
determine which of a series of figures, presented in different 
positions, coincides with the geometric model, even though this 
may have been rotated in the same plane. 3) Factor R (inductive 
reasoning) involves the capacity to resolve logical problems and 
to predict and plan, and assesses inductive and deductive 
reasoning. Such aptitudes are required for problem solving and 
planning. Participants are requested to determine the following 
letter in a given series, once they have deduced the logical series 
linking the letters. 4) Factor N (numerical calculation) involves the 
capacity to handle numbers and resolve quantitative problems 
rapidly. This ability is necessary in resolving tasks requiring a 
simple mathematical problem-solving test. The subtest consists 
of elements or problems-solving in which the participants are 
required to determine whether or not the sum of four two-digit 
numbers is correct. 5) Factor F (verbal fluency) was not 
undertaken, as it was not considered particularly relevant to the 
present study. In addition, to keep the PMA test short, each 
subject was invited to answer items with even numbers before 
the NH test (pre-PMA) and items with odd numbers after 
completing the NH test (post-PMA), respectively. Factor V 
involves attempting 25 elements in a maximum of 120 seconds, 
Factor S involves 10 elements in 150 seconds, Factor R includes 
15 elements in 180 seconds and Factor N involves 35 elements 
in 180 seconds. Each neurocognitive assessment took 630 
seconds in total, and the total number of correct answers was 
calculated. EG participants began the post-PMA test immediately 
after they had completed the NH test, which was around 3 
minutes after oxygen saturation had recovered normal values 
(SpO2 > 95%). The study was a blind two-period trial and, 
therefore, both the climbers and the psychologists carrying out 
the evaluation were unaware of the NH test results.  
To detect a learning effect and discard the possible influence 
of exercise in the laboratory, the PMA test was also performed 
twice by a control group (CG), whose participants did not take the 
NH test. The CG was made up of 8 age and sex-matched 
climbers, who were also GMAM members with similar 
experience in high and extreme altitudes. CG participants had 
not undertaken a recent ascent over 2500 m in the previous 4 
months. The CG was invited to perform even and odd items of 
the PMA test, administered before (pre-PMA) and after 30 
minutes of resting (post-PMA), respectively. Each subject in both 
the EG and CG groups performed the PMA test alone in a silent 
and comfortable room.  
 
Statistical analysis 
The Kolmogorov-Smirnov test was applied to establish the 
normal distribution of the all samples. Repeated measures 
ANOVA was then used to assess the differences between the two 
groups (EG and CG) at different time points (pre-PMA and post-
PMA). The data are expressed as mean ± SD and a significance 
level of p < .05 was used. The statistical analysis was performed 
using SPSS v.17 (SPSS Inc., Chicago, USA). 
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RESULTS 
EG climbers tolerated the NH test well, although they 
experienced a certain sensation of light-headedness. The 
climbers showed an abrupt drop of SpO2 from the beginning of 
the hypoxic phase. However, this was particularly marked during 
physical exercise, when participants achieved the worst peak 
mean values in SpO2: 71%, during the mean peak in HR: 139 
beats·min-1. However, as previously mentioned in the methods 
section, the average of all the different parameter values was 
obtained by computing the last two minutes of each phase, once 
a steady state was achieved. Physical exercise in H and N was 
performed (M and SD) at WR: 134.6 (SD = 23.7) watts, with VE in 
H: 60.4 (SD = 13.2) L·min-1, VE in N: 48.3 (SD = 10) L·min-1, HR in H: 
134.3 (SD = 9.8) beats·min-1, HR in N: 113.8 (SD = 11.3) beats·min-
1, SpO2 in H: 73.9 (SD = 6.1) %, SpO2 in N: 98.6 (SD = 1.1) %, RR in 
H: 22.2 (SD = 5.9) beats·min-1. Resting SpO2 in H was 90.2 (SD = 
2.9) % and resting SpO2 in N was 99.5 (SD = 0.7) %. Table 1 shows 
the data for individual AMS susceptibility, individual global pre-
PMA and post-PMA tests, and the total number of correct 
answers given by each EG subject. 
Data for each subject in the experimental group obtained by 
means of the normobaric hypoxic test simulating an altitude of 
4800 m., the susceptibility of acute mountain sickness (AMS), and 
the total number of correct answers in the cognitive test 
performed before (pre-PMA) and after (post-PMA) the hypoxic 
test. See the methods section for the following definitions: CRE, 
VRE, ΔSpO2E, ΔSpO2R, and RREH. *Abnormal data and AMS 
susceptibility according to Richalet & Herry (2006). Six 
participants (nos. 1, 3, 4, 6, 9 and 10) had at least one parameter 
outside the normal range. One subject (no. 1) had 3 parameters 
outside the normal range, three (nos. 3, 6 and 10) had at least 
one main parameter outside the normal range. The other two 
participants (nos. 4 and 9) had only one secondary parameter 
outside the normal range. Although the latter two probably had 
a greater susceptibility to AMS, given that their breathing was 
shallower during the hypoxic exercise, only four participants 
were classified as having a higher risk of AMS (nos. 1, 3, 6 and 
10). The 4 climbers who had the most pronounced peak 
hypoxemias (SpO2 < 70%) during the NH test (nos. 1, 3, 6 and 10), 
gave a higher number of correct answers in the post-PMA test. 
Table 1 
Individual AMS susceptibility, individual global pre-PMA and post-PMA tests, and the total of correct answers given by each EG subject. 
Subject 
CRE 
beat·min
-1
·%
-1
 
VRE 
L·min
-1
·%
-1
· kg
-1
 
ΔSpO2E 
% 
ΔSpO2R 
% 
RREH 
beat·min
-1
 
AMS risk pre-PMA post-PMA 
1 0.88 0.1 * 33 * 13 28 * High 57 64 
2 0.86 1.03 21 8 23 Low 72 69 
3 0.82 0.53 28 * 10 20 High 75 78 
4 0.77 1.43 18 3 29 * Increased 61 62 
5 1.08 0.98 24 10 24 Low 70 78 
6 0.64 0.39 37 * 11 20 High 49 60 
7 1.04 1.07 26 11 26 Low 48 57 
8 0.59 0.59 22 9 21 Low 78 71 
9 0.64 0.85 17 8 31 * Increased 74 72 
10 0.8 0.47 31 * 13 11 High 49 56 
11 0.65 0.42 20 10 18 Low 47 46 
12 1.16 0.55 19 5 15 Low 53 47 
 
Table 2 shows the total number of correct answers and the 4 
factors of the PMA test performed by EG before and immediately 
after they had finished the NH test, compared with the CG that 
was not exposed to hypoxia. The results did not show any 
statistically significant differences between the groups (p > .05). 
Table 2 
Correct answers and the 4 factors of the PMA test performed by EG 
before and immediately after they had finished the NH test, 
compared with the CG that was not exposed to hypoxia. 
 
Data expressed as number of correct answers (mean and 
standard deviation) with respect to the verbal (V), spatial (S), 
reasoning (R) and numerical (N) factors and total cognitive PMA 
test performed by the experimental group (EG) before (pre) and 
just-after (post) the hypoxic test simulating an altitude of 4800 
m, compared with the pre-post PMA by the control group (CG) 
not exposed to hypoxia. ANOVA for repeated measures in pre- 
and post-intervention between the two groups did not show 
statistical significance (p > .05).  
 
DISCUSSION AND CONCLUSION 
Overall cognitive function did not show a significant decline 
immediately after acute and brief exposure to hypoxia 
simulating an altitude of 4800 m, nor was it linked to high 
susceptibility to AMS using a specific NH test. The objective of our 
study was not to correlate the altitude symptoms with the results 
obtained in the NH test, as no specific AMS scores (e.g. 
Environmental Symptoms Questionnaire) were recorded during 
the climbers’ previous expeditions. We observed that only half of 
the participants who recalled having suffered from hypoxia-
related altitude symptoms (slight headache) also showed 
increased susceptibility to AMS in the NH test. Obviously, our 
sample was too small to obtain an overall prediction from this 
NH test, which has been shown to have high accuracy (80%) in 
distinguishing AMS susceptibility in extensive samples of 
climbers (Richalet et al., 1988), as well as in less trained 
populations (Rathat, Richalet, Herry, & Larmignat, 1992). We 
consider that the low incidence of altitude symptoms shown by 
PMA  
Factor 
intervention 
EG 
n = 12  
CG 
n = 8 
significance 
V 
pre 
post 
19.4 ± 2.7 
23.3 ± 2.6 
19.3 ± 3.1 
22.6 ± 1.8 
p > .05 
S 
pre 
post 
17.3 ± 6.6 
17.3 ± 7.2 
13.5 ± 6.4 
16.1 ± 7.3 
p > .05 
R 
pre 
post 
10.3 ± 2.9 
8.9 ± 2.9 
7.6 ± 2.4 
6.8 ± 2.8 
p > .05 
N 
pre 
post 
14.0 ± 6.3 
13.9 ± 6.3 
12.9 ± 5.8 
14.1 ± 6.5 
p > .05 
Total 
pre 61.1 ± 12.0 53.3 ± 8.9 
p > .05 
post 63.3 ± 10.7 59.6 ± 11.6 
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all our climbers may be explained by the fact that they are 
members of a professional mountaineering team and are 
accustomed to spending the recommended acclimatization time 
for high-mountain environments. However, more recently 
reported hypoxic tests have shown new data as to the estimative 
severity of AMS and the general degree of maladaptation to high 
altitude, although such tests do not involve physical exercise and 
the simulated altitude is slightly lower (Savourey et al., 2007). 
To our knowledge, only six studies have been specifically 
designed to relate AMS incidence with cognitive status by using 
real or simulated altitudes. White (1984) reported impairment in 
auditory addition and memory in participants affected by AMS 
symptoms at 3600 m, but not in those taking acetazolamide at 
the same altitude. Forster (1985) found a lower incidence of AMS 
symptoms and better numerate memory and psychomotor 
ability in participants after several days at the summit of Mt. 
Mauna Kea (4200 m) than in participants tested six hours after 
reaching the same altitude. Mackintosh et al. (1988) reported 
that reaction time was increased in those participants with 
marked symptoms of AMS at 4790 m and 5008 m during 
mountaineering expeditions. Shukitt-Hale et al. (1991) reported 
a correlation between AMS incidence and cognitive performance 
deficit in males within several hours of acute exposure to a 
simulated altitude of 4700 m. Regard et al. (1991) used 
conceptual tasks to detect a mild impairment of short-term 
memory, albeit with an improvement in cognitive flexibility, in 
mountaineers who developed AMS within several hours after a 
rapid ascent to 4559 m, compared to participants who did not 
suffer from AMS. Crowley et al. (1992) found that participants 
who were affected by AMS showed a more gradual improvement 
in cognitive performance during the hours following an acute 
ascent to a simulated altitude of 4300 m. All these studies involve 
lengths of exposure to hypoxia ranging from hours to days, 
which is the time needed to develop AMS symptoms, and 
therefore differed considerably from the short-term hypoxic 
exposure applied in the present study. Our main objective was 
to use the same procedure (specific hypoxic test) to determine 
whether AMS susceptibility in non-acclimatized participants 
could also be related to cognitive transient changes, at least 
residual ones, without having to provoke any type of high 
altitude illness.  
Persistent neurocognitive impairment after withdrawal from a 
single exposure to prolonged severe hypoxia or after repeated 
ascents to extremely high-altitudes is well-documented (Garrido 
et al., 1996; Hornbein et al., 1989; Paola et al., 2008; Regard, Oelz, 
Brugger, & Landis, 1989). Cognitive performance suffers an 
abrupt deterioration if such altitudes are reached rapidly. 
However, there is some disagreement concerning the cognitive 
slowing down induced by acute and short-term exposure to 
lower altitudes. In the experimental field, Kida & Imai (1993) did 
not detect any major changes in reaction time tasks in some 
participants exposed either to simulated altitude of 6000 m, or 
when short adaptation was carried out by means of intermittent 
simulated altitudes of up to 7000 m (Leifflen et al., 1997). Lindeis, 
Nathoo, & Fowler (1996) did not find any slow stimulus 
identification in a mental rotation task during arterial blood 
oxygen saturation at 64% while breathing gas mixtures. Noble, 
Jones, & Davis (1993) found that only minor, insignificant 
psychomotor effects with moderate hypoxemia (SaO2 ~78%) 
were induced by a similar duration and reduction in FiO2 as we 
applied in our study. Van der Post et al. (2002) detected 
significant cognitive impairment in simple reaction times, binary 
choice task and in serial word recognition in healthy participants 
a few minutes after they began to maintain a SpO2 of 80% when 
breathing gas mixtures. Wu, Li, Han, Wang, & Wei (1998) have 
reported reductions in arithmetic performance and reaction 
time one hour after a simulated altitude of almost 5000 m inside 
a hypobaric chamber, and Bartholomew et al. (1999) reported 
short-term memory deficit after spending 90 minutes at a 
simulated altitude of 3800 m. Comparing acclimatized and non-
acclimatized participants exposed to 6000 m inside a hypobaric 
chamber, Koller et al. (1991) reported significant mental 
arithmetic errors only in the latter group. Nevertheless, few 
studies have introduced physical exercise during the hypoxic 
exposure, and therefore a significant increase in the degree of 
hypoxia would be expected. Paul & Fraser (1994) did not detect 
any impairment in the ability to learn new tasks when 
participants performed light physical exercise at simulated 
altitudes below 3700 m. Knight, Schlichting, Fulco, & Cymerman 
(1990) demonstrated that several hours of exposure at the same 
simulated altitude (FiO2 13%) seemed sufficient to develop 
psychomotor impairment, but this, however, was not related to 
submaximal exercise. Moreover, it has been suggested that 
helicopter aircrews should be aware that even very light physical 
activity (4 minutes cycling at a work rate of 60 watts) under acute 
exposure as low as 2134 m may produce hypoxemia and mental 
symptoms similar to those normally expected in a person resting 
at an altitude approximately between 3600 m and 4600 m 
(Smith, 2007). Likewise, an interesting topic of study is the effects 
on cognitive processes immediately after a hypoxic situation, as 
occurs in some critical illnesses. The presence of residual 
neuropsychological effects may depend on the length and 
degree of decreased oxygen delivery to the brain, and 
neurocognitive sequelae seem common and may be permanent 
(Hopkins & Jackson, 2006). However, impairment may slowly 
improve within several months of an early post-acute 
confusional state caused by sudden and brief hypoxic episode 
(Lim et al., 2004). 
We observed that our participants in both EG and CG groups 
provided slightly more correct answers during the second PMA 
test, due to an improvement in Factor V. This may be the result 
of a learning effect, as this particular factor requires the simplest 
cognitive task, in that it tests basic verbal comprehension 
abilities related to daily language use. Although, with the 
exception of factor S, cognition tended to decline in the other two 
cognitive factors (R and N) in tests performed by EG participants, 
we did not find any significant differences between their pre-
PMA and post-PMA scores. However, the four participants who 
had the lowest peak values of SpO2 during the NH test, and 
consequently those with the highest AMS susceptibility, 
unexpectedly performed slightly better in the post-PMA test. The 
other participants (with the exception of nos. 5 and 7) who had a 
brisk ventilatory response to hypoxia, showed a greater decline 
in scores on the post-PMA test. We cannot rule out the possibility 
that this observation may be related to the complex mechanisms 
involved in cerebral blood flow regulation during altitude 
exposure, which depends mainly on the degree of hypoxia and 
on individual sensitivity to oxygen and carbon dioxide balance 
Pedro Allueva, Eduardo Garrido, Casimiro Javierre, Jorge Palop y Javier Aceña 
 
226 Revista Iberoamericana de Psicología del Ejercicio y el Deporte. Vol. 11, nº 2 (2016) 
 
(Brugniaux, Hodges, Hanly, & Poulin, 2007). The NH test designed 
by Richalet et al. (1988) assesses the ventilatory response in the 
poikilocapnic hypoxia condition. In other words, the alveolar 
carbon dioxide pressure is free to vary as a consequence of 
ventilation changes with hypoxia. This condition has been shown 
to cause a biphasic response of cerebrovascular resistance, with 
an initial drop in blood flow mediated by hypocapnia within the 
first minutes of acute inhalation of half of the normal alveolar 
oxygen pressure (Steinback & Poulin, 2008). A higher level of 
hypocapnia induced by physical exercise following intermittent 
hypoxia exposure has been shown to cause a significant 
decrease in cerebral oxygenation at a simulated altitude of 
around 3200 m (Ainslie, Hamlin, Hellemans, Rasmussen, & Ogoh, 
2008). Nevertheless, a more recent study challenged the notion 
that hypocapnia was the main deoxygenation mechanism in 
cognitive prefrontal brain areas during peak exercise under 
acute and short-term exposure to a simulated altitude of 4700 m 
(Subudhi, Miramon, Granger, & Roach, 2009).  
Nor did we detect any significant differences between the 
groups in the four PMA subtests; however, the worst 
performance was in Factor R, which tended to decline more 
sharply in climbers who underwent the NH test. This sub-test 
explores inductive reasoning related to the function of the 
frontal lobe brain areas, which are particularly vulnerable to 
hypoxic insults. Comprehension processing difficulty was 
strongly associated with damage to prefrontal cortex pathways 
in extreme altitude climbers (Lieberman, Protopapas, Reed, 
Young, & Kanki, 1994). Recent findings have shown hypoxia-
induced performance deficits using electromagnetic 
tomography after short exposure (40 minutes) to a simulated 
altitude of approximately 4000 m, and such deficits have been 
related to changes in the cortical activity of prefrontal areas 
(Schneider & Strüder, 2009). However, although changes in 
cerebral excitability caused by a lack of oxygen seem to be an 
important factor in producing AMS symptoms, hypoxia cannot 
probably explain the whole neuropsychological and clinical 
picture of this altitude sickness, as was recently reported (Miscio 
et al., 2009). It is probable that a variety of mechanisms are 
involved, due to the evidence of the dissociation of the time 
course between AMS, cognitive changes and also moods during 
sustained hypoxic exposure (Banderet & Burse, 1991; Shukitt-
Hale et al., 1991). 
Psychological reactions brought on by the hazardous 
environment of high altitudes, whether terrestrial or aerial, were 
rejected on the basis of an NH test performed in a laboratory. 
However, our study did not assess cognitive function during the 
hypoxic exposure, even though the climbers performed the post-
PMA immediately after completing the NH test. If this type of 
hypoxic test causes a significant cognitive slowing down, 
recovery must occur rapidly a few minutes after the hypoxia 
stops. We must take into account that this type of NH test 
consists of a sudden hypoxic stress that adds physical exercise 
and is consequently more aggressive to brain oxygenation than 
acute hypoxia, in which the peak degree is achieved 
progressively in several steps within minutes or hours while 
resting. In our experience, this type of NH test induces a hypoxic 
syncope in a few cases, but tends to provoke a certain dazed 
sensation in many people. Therefore, we do not rule out the 
possibility that there may be some transient mental dysfunction 
during the hypoxic phases of the test. Technical problems make 
it impossible to perform the PMA test during this type of NH test, 
as gas exchange is continuously monitored by means of a 
pneumotachograph connected to mouth valve multipiece tubes, 
while the subject performs relatively intense physical exercise 
while both checking a display in order to maintain a steady 
cycling pace and holding the handle bar of the cycle ergometer. 
This test situation may produce methodological errors, even 
during a simple cognitive assessment, that are not associated 
exclusively with the hypoxic stress. Finally, the Thurstone test 
was included in a study in mountaineers that enabled detection 
of the presence of cognitive impairment after repeated 
extremely high-altitude climbs (Regard et al., 1989), and we 
consider that the PMA test could be useful for cognitive 
evaluation during stances in high mountains, due to its 
simplicity, rapid execution and easy interpretation, even by non-
scientific personal. Nevertheless, the results do not support our 
initial hypothesis, and consequently, for prior detection of 
participants who are at particular AMS and cognitive risks, we 
suggest that complex task performance needs to be evaluated 
by applying other specific tests of normobaric or hypobaric 
hypoxia characterized by longer exposure to oxygen deprivation, 
like some recently reported models (Savourey et al., 2007).  
Basic cognitive function does not seem to be impaired 
immediately after short and sudden hypoxic exposure 
corresponding to an altitude of almost 5000 m, and no link was 
established between AMS risk and cognitive dysfunction by 
means of the procedures applied. Our results suggest that rapid 
ascents with very brief stays below extreme altitudes, even when 
performing moderate physical exercise, as is the case in some 
aerial or mountain activities, seem to be cognitively safe despite 
the susceptibility to AMS, at least in non-acclimatized males with 
previous experience of high terrestrial altitudes. Nevertheless, 
future studies including complex task evaluation in larger 
numbers of participants are necessary if we are to provide a 
predictive value between AMS and cognitive susceptibilities on 
the basis of a single, and probably longer, hypoxic test. Can also 
be incorporated studies of Event-Related Potential (ERP), widely 
used to assess how the human brain normally processes 
information (Hernández, 2007). 
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